Helicobacter Pylori Non-Invasive Testing Market By Non-invasive Test Type (Serology Tests, Stool Antigen Tests, Urea Breath Tests), By Test Type (Laboratory-based Tests, Point-of-Care Tests), By End User & By Region - Global Market Insights 2023 to 2033

Feb 2023| FMR811B| Fact Market Research

Report Highlights

Helicobacter Pylori Non-Invasive Testing Market - Scope of Report

A recent study by Fact.MR on the helicobacter pylori non-invasive testing market offers a 10-year forecast for 2023 to 2033. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering helicobacter pylori non-invasive testing.

The study also provides the dynamics responsible for influencing the future status of the helicobacter pylori non-invasive testing market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies operating in the helicobacter pylori non-invasive testing market, along with their product portfolios, key strategies and SWOT analysis, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of helicobacter pylori non-invasive testing across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of helicobacter pylori non-invasive testing during the forecast period. Price point comparison by region with global average price is also considered in the study.

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of value (US$ Mn).

Estimates at global and regional levels for helicobacter pylori non-invasive testing are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report.

Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global helicobacter pylori non-invasive testing market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the helicobacter pylori non-invasive testing market during the forecast period.

Country-specific valuation on demand for helicobacter pylori non-invasive testing has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

In-depth Analysis on Competition

The report sheds light on leading manufacturers of helicobacter pylori non-invasive testing, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering helicobacter pylori non-invasive testing has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the helicobacter pylori non-invasive testing domain.

  • Table 1 : Global Market Value (US$ Mn) Forecast, by Non-invasive Test Type, 2023–2033
  • Table 2 : Global Market Value (US$ Mn) Forecast, by Test Method, 2023–2033
  • Table 3 : Global Market Value (US$ Mn) Forecast, by End User, 2023–2033
  • Table 4 : Global Market Value (US$ Mn) Forecast, by Region, 2023–2033
  • Table 5 : North America Market Revenue (US$ Mn) Forecast, by Country, 2023–2033
  • Table 6 : North America Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2023–2033
  • Table 7 : North America Market Revenue (US$ Mn) Forecast, by Test Method, 2023–2033
  • Table 8 : North America Market Revenue (US$ Mn) Forecast, by End User, 2023–2033
  • Table 9 : Europe Market Revenue (US$ Mn) Forecast, by Country, 2023–2033
  • Table 10 : Europe Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2023–2033
  • Table 11 : Europe Market Revenue (US$ Mn) Forecast, by Test Method, 2023–2033
  • Table 12 : Europe Market Revenue (US$ Mn) Forecast, by End User, 2023–2033
  • Table 13 : Asia Pacific Market Revenue (US$ Mn) Forecast, by Country, 2023–2033
  • Table 14 : Asia Pacific Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2023–2033
  • Table 15 : Asia Pacific Market Revenue (US$ Mn) Forecast, by Test Method, 2023–2033
  • Table 16 : Asia Pacific Market Revenue (US$ Mn) Forecast, by End User, 2023–2033
  • Table 17 : Latin America Market Revenue (US$ Mn) Forecast, by Country, 2023–2033
  • Table 18 : Latin America Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2023–2033
  • Table 19 : Latin America Market Revenue (US$ Mn) Forecast, by Test Method, 2023–2033
  • Table 20 : Latin America Market Revenue (US$ Mn) Forecast, by End User, 2023–2033
  • Table 21 : Middle East & Africa Market Revenue (US$ Mn) Forecast, by Country, 2023–2033
  • Table 22 : Middle East & Africa Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2023–2033
  • Table 23 : Middle East & Africa Market Revenue (US$ Mn) Forecast, by Test Method, 2023–2033
  • Table 24 : Middle East & Africa Market Revenue (US$ Mn) Forecast, by End User, 2023–2033
  • Figure 1 : Prevalence of Helicobacter Pylori, North America, 2022
  • Figure 2 : Prevalence of Helicobacter Pylori, Europe, 2022
  • Figure 3 : Prevalence of Helicobacter Pylori, Asia Pacific, 2022
  • Figure 4 : Prevalence of Helicobacter Pylori, Latin America, 2022
  • Figure 5 : Prevalence of Helicobacter Pylori, Middle East & Africa, 2022
  • Figure 6 : Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, 2023–2033
  • Figure 7 : Opportunity Map, by Non-invasive Test Type and Test Method, 2022
  • Figure 8 : Opportunity Map, by End User, 2022
  • Figure 9 : Global Market Value Share, by Region (2022)
  • Figure 10 : Global Market Value Share, by Test Method (2022)
  • Figure 11 : Global Market Value Share, by Non-Invasive Test Type (2022)
  • Figure 12 : Global Market Value Share, by End-user (2022)
  • Figure 13 : Global Market Value Share, by Non-invasive Test Type, 2020 and 2026
  • Figure 14 : Global Market Revenue (US$ Mn), by Serology Test, 2023–2033
  • Figure 15 : Global Market Revenue (US$ Mn), by SAT, 2023–2033
  • Figure 16 : Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by UBT, 2023–2033
  • Figure 17 : Global Market Attractiveness, by Non-invasive Test Type, 2023–2033
  • Figure 18 : Global Market Value Share, by Test Method, 2020 and 2026
  • Figure 19 : Global Market Attractiveness, by Test Method, 2023–2033
  • Figure 20 : Global Market Revenue (US$ Mn), by Laboratory Based Tests, 2023–2033
  • Figure 21 : Global Market Revenue (US$ Mn), by Point-of-Care Tests, 2023–2033
  • Figure 22 : Global Market Value Share, by End User, 2020 and 2026
  • Figure 23 : Global Market Attractiveness, by End User, 2023–2033
  • Figure 24 : Global Market Revenue (US$ Mn), by Hospitals, 2023–2033
  • Figure 25 : Global Market Revenue (US$ Mn), by Clinics, 2023–2033
  • Figure 26 : Global Market Revenue (US$ Mn), by Diagnostic Labs, 2023–2033
  • Figure 27 : Global Market Value Share (%), by Region, 2020 and 2026
  • Figure 28 : Global Market Attractiveness, by Region, 2023–2033
  • Figure 29 : North America Market Value Share, by Country, 2020 and 2026
  • Figure 30 : North America Market Attractiveness, by Country, 2023–2033
  • Figure 31 : North America Market Value Share, by Non-invasive Test Type, 2020 and 2026
  • Figure 32 : North America Market Attractiveness, by Non-invasive Test Type, 2023–2033
  • Figure 33 : North America Market Value Share, by Test Method, 2020 and 2026
  • Figure 34 : North America Market Attractiveness, by Test Method, 2023–2033
  • Figure 35 : North America Market Value Share, by End User, 2020 and 2026
  • Figure 36 : North America Market Attractiveness, by End User, 2023–2033
  • Figure 37 : Europe Market Value Share, by Country, 2020 and 2026
  • Figure 38 : Europe Market Attractiveness, by Country, 2023–2033
  • Figure 39 : Europe Market Value Share, by Non-invasive Test Type, 2020 and 2026
  • Figure 40 : Europe Market Attractiveness, by Non-invasive Test Type, 2023–2033
  • Figure 41 : Europe Market Value Share, by Test Method, 2020 and 2026
  • Figure 42 : Europe Market Attractiveness, by Test Method, 2023–2033
  • Figure 43 : Europe Market Value Share, by End User, 2020 and 2026
  • Figure 44 : Europe Market Attractiveness, by End User, 2023–2033
  • Figure 45 : Asia Pacific Market Value Share, by Country, 2020 and 2026
  • Figure 46 : Asia Pacific Market Attractiveness, by Country, 2023–2033
  • Figure 47 : Asia Pacific Market Value Share, by Non-invasive Test Type, 2020 and 2026
  • Figure 48 : Asia Pacific Market Attractiveness, by Non-invasive Test Type, 2023–2033
  • Figure 49 : Asia Pacific Market Value Share, by Test Method, 2020 and 2026
  • Figure 50 : Asia Pacific Market Attractiveness, by Test Method, 2023–2033
  • Figure 51 : Asia Pacific Market Value Share, by End User, 2020 and 2026
  • Figure 52 : Asia Pacific Market Attractiveness, by End User, 2023–2033
  • Figure 53 : Latin America Market Value Share, by Country, 2020 and 2026
  • Figure 54 : Latin America Market Attractiveness, by Country, 2023–2033
  • Figure 55 : Latin America Market Value Share, by Non-invasive Test Type, 2020 and 2026
  • Figure 56 : Latin America Market Attractiveness, by Non-invasive Test Type, 2023–2033
  • Figure 57 : Latin America Market Value Share, by Test Method, 2020 and 2026
  • Figure 58 : Latin America Market Attractiveness, by Test Method, 2023–2033
  • Figure 59 : Latin America Market Value Share, by End User, 2020 and 2026
  • Figure 60 : Latin America Market Attractiveness, by End User, 2023–2033
  • Figure 61 : Middle East & Africa Market Value Share, by Country, 2020 and 2026
  • Figure 62 : Middle East & Africa Market Attractiveness, by Country, 2023–2033
  • Figure 63 : Middle East & Africa Market Value Share, by Non-invasive Test Type, 2020 and 2026
  • Figure 64 : Middle East & Africa Market Attractiveness, by Non-invasive Test Type, 2023–2033
  • Figure 65 : Middle East & Africa Market Value Share, by Test Method, 2020 and 2026
  • Figure 66 : Middle East & Africa Market Attractiveness, by Test Method, 2023–2033
  • Figure 67 : Middle East & Africa Market Value Share, by End User, 2020 and 2026
  • Figure 68 : Middle East & Africa Market Attractiveness, by End User, 2023–2033
  • Figure 69 : Global Helicobacter Pylori (H. Pylori) Non-invasive Testing, Company Share Analysis, 2022 (Estimated)
  • Figure 70 : DiaSorin S.p.A Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022
  • Figure 71 : DiaSorin S.p.A Breakdown of Net Sales (%), by Region, 2022
  • Figure 72 : Meridian Bioscience, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022
  • Figure 73 : Meridian Bioscience, Inc. Breakdown of Net Sales (%), by Business Segment, 2022
  • Figure 74 : Exalenz Bioscience Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022
  • Figure 75 : Exalenz Bioscience Ltd. R&D Expenditure (US$ Mn), 2018-2022
  • Figure 76 : Alere (Abbott) Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022
  • Figure 77 : Alere (Abbott) Breakdown of Net Sales (%), by Business Segment, 2022
  • Figure 78 : Thermo Fisher Scientific Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022
  • Figure 79 : Thermo Fisher Scientific Breakdown of Net Sales (%), by Business Segment, 2022

Fact.MR is an independent, pure play market intelligence firm incorporated with an objective to deliver high quality, customized market research solutions that help our clients successfully go to the market equipped with actionable insights capable of impacting crucial business decisions.

Similar Reports from Fact Market Research

Helicobacter Pylori (H-Pylori) Non-Invasive Testing Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2026

  • Date - May 2020
  • Code - FMR811A

Global Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market- Scope of the Report

The recent study by Fact.MR on global helicobacter pylori (h. pylori) Non-invasive testing market offers a 6-year forecast between 2020 and 2026. The study analyzes crucial trends that are currently determining the growth of global helicobacter pylori (h. pylori) Non-invasive testing market. This report explicates on vital dynamics ...

Fact Market Research
Price: $4500

Become a Member

Already a member? Login here.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.